The clinical relevance and prognostic significance of HER2/Neu in gastric cancers

BackgroundGastric cancer (GC) still represents a major health problem, despite a decrease in its incidence in the last few years. Because of the social impact of GC, there is a need for developing novel biomarkers to stratify patients into appropriate screening, surveillance, or treatment programs.